Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

JCI’s Conversations with Giants in Medicine: Elizabeth Blackburn and Viviane Tabar

While great strides have been made with regard to gender equity in biomedical academia, there remains a stubborn imbalance in representation in senior leadership roles. The graduate students from the Gerstner Sloan Kettering Graduate School have launched a series called The Roots of Change: Conversations about Women’s Empowerment to grapple with the issue of representation. They invited two giants in medicine to reflect on their lives in medicine: Viviane Tabar and Elizabeth Blackburn. Dr. Tabar is the chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center and leads a stem cell biology lab focusing on the development of human embryonic stem cell–derived dopaminergic neurons for the treatment of Parkinson’s disease, among other cell-based therapies for the repair of brain injuries. Dr. Blackburn is the former president of the Salk Institute for Biomedical Studies and, before that leadership position, had a long career on the faculty at the University of California, Berkeley, and UC San Francisco. She is best known for her scientific work on telomeres; she shared the 2009 Nobel Prize in Physiology or Medicine for the discovery of telomerase. The first hour of the Roots of Change conversation, with feminist icon and writer Gloria Steinem, is available on the Sloan Kettering website (https://www.mskcc.org/watch-conversations-about-women-s-empowerment).

Published June 1, 2022, by Ushma S. Neill

Conversations with Giants in Medicine

Related articles

A conversation with Elizabeth Blackburn and Viviane Tabar
Inés Fernández Maestre, … , Brianna Naizir, Ushma S. Neill
Inés Fernández Maestre, … , Brianna Naizir, Ushma S. Neill
Published June 1, 2022
Citation Information: J Clin Invest. 2022;132(11):e161661. https://doi.org/10.1172/JCI161661.
View: Text | PDF
Conversations with Giants in Medicine

A conversation with Elizabeth Blackburn and Viviane Tabar

  • Text
  • PDF
Abstract

Authors

Inés Fernández Maestre, Yanyang Chen, Brianna Naizir, Ushma S. Neill

×
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts